Clinical trial
A Randomized, Open-Label, Multi-Center Study to Compare the Safety and Efficacy of Apligraf Versus Standard Therapy (i.e., Saline Moistened Dressing Regimen) in the Treatment of Diabetic (Primarily Neuropathic) Foot Ulcers
NCT00512538 is registered in ClinicalTrials.gov with Organogenesis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open-Label, Multi-Center Study to Compare the Safety and Efficacy of Apligraf Versus Standard Therapy (i.e., Saline Moistened Dressing Regimen) in the Treatment of Diabetic (Primarily Neuropathic) Foot Ulcers
- Lead sponsor
- Organogenesis
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- October 31, 2000
- Completion date
- September 30, 2002
- Enrollment
- 82 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.